Has Christopher Oconnell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $76,016 in general payments to Christopher Oconnell, MD across 269 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Oconnell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Oconnell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Oconnell, MD

Procedural Dermatology · Coral Gables, FLNPI 1598934671

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $63,650 of the $76,016 with a category attached, or 83.7%. Galderma Laboratories, L.p. accounts for 81.0% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $18,975 and has fallen 80.6% since, to $3,681 in 2025. Among procedural dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$76,016in general payments, 2019–2025

Across 269 payments — averaging $282.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Galderma Laboratories, L.p.$62K
Revance Therapeutics, Inc.$6K
AbbVie$6K
Merz North America, Inc.$268
Regeneron Healthcare Solutions, Inc.$254
Sun Pharmaceutical Industries Inc.$133
plus $1K from 21 others

$850in research payments, 2019–2025

Across 6 payments — averaging $141.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$850

What the payments were for

Speaking & faculty fees$63,65084%
Travel & lodging$9731%
Food & beverage$11,39315%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Galderma Laboratories, L.p.	68	$61,566
Revance Therapeutics, Inc.	15	$6,327
AbbVie(2 entities)	101	$6,249
Merz North America, Inc.	9	$268
Regeneron Healthcare Solutions, Inc.	12	$254
Sun Pharmaceutical Industries Inc.	6	$133
Dermira, Inc.	6	$126
Arcutis Biotherapeutics, Inc.	6	$121
E.r. Squibb & Sons, L.L.C.	3	$91
Incyte Corporation	5	$86
Solta Medical, A Division Of Bausch Health US, LLC	4	$83
Almirall LLC	4	$83
Lilly USA, LLC	4	$79
Pfizer	4	$65
Boehringer Ingelheim	2	$65
Aclaris Therapeutics, Inc.	3	$64
Amgen	2	$63
Novartis	2	$52
Johnson & Johnson	2	$39
Sanofi	2	$38
VYNE Pharmaceuticals Inc.	1	$36
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$29
EPI Health, LLC	2	$28
Covidien LP	1	$22
Promius Pharma LLC	1	$20
Biofrontera Inc.	1	$17
Merck	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DAXXIFY$5,532
BOTOX COSMETIC$500

How this compares

$76,016 in reported general payments places this provider in the 90th percentile of 60 procedural dermatology providers in Florida.

See all procedural dermatology providers in Florida →

Medicare billing

Part B allowed, 2024

$72,064

Medicare patients

228

Services billed

1,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	19	$736
Clindamycin Phosphate	12	$410
CiclopiroxCiclopirox Olamine	15	$316
ValacyclovirValacyclovir Hcl	17	$258
Triamcinolone Acetonide	21	$196
Mupirocin	11	$142
Ketoconazole	12	$135

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Coral Gables

Luis SoroFort Lauderdale$307K
Laertes ManuelidisFort Myers$252K
Michael ScannonTampa$218K
Dimitry PalceskiWinter Park$23K
Samantha MarroneOrlando$22K
Robert BrownOrange Park$22K
Ileana Perez-QuintairosSouth Miami$16K
Lawrence StrongWellington$13K
Melanie HaynesPinellas Park$9K
Ronald KnipeOrlando$6K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →